Immunophenotyping in multiple myeloma and related plasma cell disorders

被引:90
作者
Kumar, Shaji [1 ]
Kimlinger, Teresa
Morice, William
机构
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
关键词
monoclonal gammopathy; myeloma; plasma cell; immunophenotyping; MULTIPARAMETER FLOW-CYTOMETRY; MINIMAL RESIDUAL DISEASE; LOW CD27 EXPRESSION; HIGH-DOSE THERAPY; BONE-MARROW; PERIPHERAL-BLOOD; MONOCLONAL GAMMOPATHY; LABELING INDEXES; UNDETERMINED SIGNIFICANCE; C-KIT;
D O I
10.1016/j.beha.2010.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma cell disorders form a spectrum ranging from the asymptomatic presence of small monoclonal populations of plasma cells to conditions like plasma cell leukemia and multiple myeloma, in which the bone marrow can be replaced by the accumulation of neoplastic plasma cells. Immunophenotyping has become an invaluable tool in the management of hematological malignancies and is increasingly finding a role in the diagnosis and monitoring of plasma cell disorders. Multiparameter flow cytometry has evolved considerably during the past decade with an increasing ability to screen large numbers of events and to detect multiple antigens at the same time. This, along with a better understanding of the phenotypic heterogeneity of the clonal plasma cells in different disorders, has made immunophenotyping an indispensible tool in the diagnosis, prognostic classification and management of plasma cell disorders. This book chapter addresses the approaches taken to evaluate monoclonal plasma cell disorders, and the different markers and techniques that are important for the study of these diseases. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:433 / 451
页数:19
相关论文
共 100 条
[91]   Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders [J].
Witzig, TE ;
Timm, M ;
Larson, D ;
Therneau, T ;
Greipp, PR .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (01) :131-137
[92]  
WITZIG TE, 1993, CANCER, V72, P108, DOI 10.1002/1097-0142(19930701)72:1<108::AID-CNCR2820720121>3.0.CO
[93]  
2-T
[94]   T-CELL DEPLETION USING ANTI-CD2 COATED MAGNETIC BEADS SIMPLIFIES THE DETECTION OF PERIPHERAL-BLOOD PLASMA-CELLS [J].
WITZIG, TE ;
GONCHOROFF, NJ ;
AHMANN, GA ;
KATZMANN, JA ;
GREIPP, PR .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 144 (02) :253-256
[95]  
Witzig TE, 1996, CYTOMETRY, V26, P113, DOI 10.1002/(SICI)1097-0320(19960615)26:2<113::AID-CYTO3>3.0.CO
[96]  
2-H
[97]   DETECTION OF PERIPHERAL-BLOOD PLASMA-CELLS AS A PREDICTOR OF DISEASE COURSE IN PATIENTS WITH SMOLDERING MULTIPLE-MYELOMA [J].
WITZIG, TE ;
KYLE, RA ;
OFALLON, WM ;
GREIPP, PR .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (02) :266-272
[98]  
Witzig TE, 1996, BLOOD, V88, P1780
[99]   PERIPHERAL BLOOD-B CELL LABELING INDEXES ARE A MEASURE OF DISEASE-ACTIVITY IN PATIENTS WITH MONOCLONAL GAMMOPATHIES [J].
WITZIG, TE ;
GONCHOROFF, NJ ;
KATZMANN, JA ;
THERNEAU, TM ;
KYLE, RA ;
GREIPP, PR .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (06) :1041-1046
[100]   CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy [J].
Zhou, Ping ;
Comenzo, Raymond L. ;
Olshen, Adam B. ;
Bonvini, Ezio ;
Koenig, Scott ;
Maslak, Peter G. ;
Fleisher, Martin ;
Hoffman, James ;
Jhanwar, Suresh ;
Young, James W. ;
Nimer, Stephen D. ;
Boruchov, Adam M. .
BLOOD, 2008, 111 (07) :3403-3406